Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesCardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery
Trends in Pharmacological Sciences, 09/18/09
Braam SR et al. – The availability of human cardiomyocytes from stem cell sources is expected to accelerate the discovery of cardiac drugs and safety pharmacology by offering more clinically relevant human culture models than presently available. The authors review the state–of–the–art using stem cell–derived human cardiomyocytes in drug discovery, drug safety pharmacology, and regenerative medicine.
Related Articles
Effects of fibroblast-myocyte coupling on cardiac conduction and vulnerability to reentry: A computational study
Heart Rhythm, 11/06/09
Relevance Score: 69%
Dystroglycan Matrix Receptor Function in Cardiac Myocytes Is Important for Limiting Activity-Induced Myocardial Damage
Circulation Research, 10/02/09
Relevance Score: 69%
Temporal Responses to Intrinsically Coupled Calcium and Zinc Dyshomeostasis in Cardiac Myocytes and Mitochondria During Aldosteronism
Heart And Circulatory Physiology, 11/19/09
Relevance Score: 66%
Pleiotropic effects of neutrophils on myocyte apoptosis and left ventricular remodeling during early volume overload
Journal of Molecular and Cellular Cardiology, 10/19/09
Relevance Score: 66%
Sub-lethal doses of an anti-erbB2 antibody leads to death by apoptosis in cardiomyocytes sensitized by low pro-senescent doses of epirubicin: the protective role of dexrazoxane
Journal of Pharmacology and Experimental Therapeutics, 10/26/09
Relevance Score: 65%
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Evaluation of arterial stiffness in morning hypertension under high-dose valsartan compared to valsartan plus low-dose diuretic
Hypertension Research, 12/17/09
Telmisartan/amlodipine: approved for high blood pressure
Formulary , 12/16/09
Clopidogrel Hypersensitivity: A Novel Multi-Day Outpatient Oral Desensitization Regimen
Annals of Pharmacotherapy, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor